Chronic Lymphocytic Leukemia

>

Latest News

FDA Updates Fludarabine Labeling Under Project Renewal Initiative
FDA Updates Fludarabine Labeling Under Project Renewal Initiative

November 20th 2024

The FDA updated the fludarabine phosphate injection labeling under Project Renewal, clarifying the dosage for combination therapy and streamlining safety warnings.

Exploring New Therapies and Sequencing in Relapsed CLL
Exploring New Therapies and Sequencing in Relapsed CLL

November 14th 2024

Advancements in CLL: CAR T, BTK Inhibitors and Personalized Medicine
Advancements in CLL: CAR T, BTK Inhibitors and Personalized Medicine

November 13th 2024

Genetic Risk Score Offers Insight Into CLL Predisposition
Genetic Risk Score Offers Insight Into CLL Predisposition

November 6th 2024

Breakthroughs and Challenges in BCL-2 Inhibitor Therapy for CLL Treatment
Breakthroughs and Challenges in BCL-2 Inhibitor Therapy for CLL Treatment

October 24th 2024

Video Series
Video Interviews
Podcasts

More News